obesity

Arena Looks To Be The Clear Winner In The Weight Loss Space

Arena Looks To Be The Clear Winner In The Weight Loss Space

Seeking Alpha

Why Arena's Launch Will Be Strong, Despite Vivus' Weak Launch

Why Arena's Launch Will Be Strong, Despite Vivus' Weak Launch

Motley Fool

The Wild October Ride Of Vivus

The Wild October Ride Of Vivus

Seeking Alpha

Submitted by moderatorj on Tue, 10/30/2012 - 23:17

Obesity: Allergan may sell Lap-Band business

Obesity: Allergan may sell Lap-Band business

Mass Device

Allergan says exploring sale of obesity business

Allergan says exploring sale of obesity business

Reuters

Analysts Objectivity in Coverage of the Obesity Space

Analysts Objectivity in Coverage of the Obesity Space

Motley Fool

A Looming Threat for Arena and VIVUS

A Looming Threat for Arena and VIVUS

Motley Fool

Analysts Objectivity in Coverage of the Obesity Space

Analysts Objectivity in Coverage of the Obesity Space

Motley Fool

FDA Lightens Up on Obesity Drugs

FDA Lightens Up on Obesity Drugs

Motley Fool

What Does This Rejection Mean for Obesity Drugmakers?

What Does This Rejection Mean for Obesity Drugmakers?

Motley Fool